Drug · DIN 02413752
PMS-METHYLPHENIDATE ER
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 29, 2019; first marketed March 3, 2014.
- Drug Identification Number (DIN)
- 02413752
- Company (DIN owner)
- Pharmascience Inc.Montreal, Quebec, Canada
- Schedule
- Controlled drugs (CDSA III)
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Methylphenidate N06BA04
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| METHYLPHENIDATE HYDROCHLORIDE | 54 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 10, 2013: NOC 14796Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “pms-methylphenidate”. A notice may cover another product or only some lots: read it to see what it covers.
- PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidateJuly 4, 2025 · Drugs · Product quality · Type I
- pms-Méthylphénidate ER (2017-10-10)October 19, 2017 · Drugs · Product safety · Type II
Other DINs named PMS-METHYLPHENIDATE ER
- DIN 02413728 · Cancelled Post Market
- DIN 02413736 · Cancelled Post Market
- DIN 02413744 · Cancelled Post Market